References
- Farber E, Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res 51, 2751-2761, 1991.
- Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74, 533-544, 2007. https://doi.org/10.1016/j.bcp.2007.02.014
- Kawanishi S, Oikawa S, Murata M. Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal 7, 1728-1739, 2005. https://doi.org/10.1089/ars.2005.7.1728
- Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM, Feinstein E. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21, 6017-6031, 2002. https://doi.org/10.1038/sj.onc.1205877
- Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460, 2008. https://doi.org/10.1016/j.cell.2008.06.028
- Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187, 1998. https://doi.org/10.1038/34432
- Greer EL Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282, 30107-30119, 2007. https://doi.org/10.1074/jbc.M705325200
- Wang X, Proud CG. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21, 362-369, 2006. https://doi.org/10.1152/physiol.00024.2006
- Peng T, Golub TR, Sabatini DM. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 22, 5575-5584, 2002. https://doi.org/10.1128/MCB.22.15.5575-5584.2002
- Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-293, 2005. https://doi.org/10.1016/j.molcel.2005.03.027
- Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Vardaki E, Perakis K, Stratigis S, Passam A, Papadogiorgaki E, Giannakakis K, Nakopoulou L, Daphnis E. The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dial Transplant 26, 498-508, 2011. https://doi.org/10.1093/ndt/gfq496
-
Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and
$NF-{\kappa}B$ inhibition. Eur J Pharmacol 649, 84-91, 2010. https://doi.org/10.1016/j.ejphar.2010.09.020 - Chien SY, Wu YC, Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ, Chen DR. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 28, 493-503, 2009. https://doi.org/10.1177/0960327109107002
- Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136, 2715-2721, 2006. https://doi.org/10.1093/jn/136.11.2715
- Lee YK, Hwang JT, Kwon DY, Surh YJ, Park OJ. Induction of apoptosis by quercetin is mediated through AMPKalpha1/ ASK1/p38 pathway. Cancer Lett 292, 228-236, 2010. https://doi.org/10.1016/j.canlet.2009.12.005
- Lee SH, Kim IS, Park SY, Park OJ, Kim YM. Quercetin induced apoptosis via regulation of mTOR-VASP signaling pathway in HT-29 colon cancer cells. Cancer Pre Res 16, 340-347, 2011.
- Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, Kim SJ, Kim J, Choi C, Kim JS, Cho SD, Jung JW, Roh KH, Kang KS, Jung JY. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem 58, 8643-8650, 2010. https://doi.org/10.1021/jf101510z
- Huang S, Bjornsti MA, Houghton PJ. Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther 2, 222-232, 2003. https://doi.org/10.4161/cbt.2.3.360
- Zakikhani M, Blouin MJ, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat 123, 271-279, 2010. https://doi.org/10.1007/s10549-010-0763-9
- Shin BY, Jin SH, Cho IJ, Ki SH. Nrf2-ARE pathway regulates induction of Sestrin-2 expression. Free Radic Biol Med 4, 834-841, 2012.
- Liu XM, Peyton KJ, Shebib AR, Wang H, Durante W. Compound C stimulates heme oxygenase-1 gene expression via the Nrf2-ARE pathway to preserve human endothelial cell survival. Biochem Pharmacol 4, 371-379, 2011.